Mahima Datla

Early Life

Mahima Datla's early life details are not widely available in public sources. However, it is known that she is part of the Datla family, who founded Biological E. Limited. She pursued a Bachelor's Degree in Business Administration Management from Webster University, London, setting the stage for her future leadership role.

Rise to Success

Mahima Datla joined Biological E. Limited (BE) in 2001, where she gained experience in project management, building quality systems and driving operations. She became the Managing Director in 2013, taking on a key leadership position within the company. Under her leadership, BE has strengthened its presence in the vaccine market, including the development of CORBEVAX, India's first indigenously developed protein sub-unit Covid-19 vaccine. In 2022, she resolved a decade-long ownership dispute within the company.

Key Business Strategies

Datla's strategies have focused on expanding BE's infrastructure and exploring opportunities for capital access. Her focus has been on driving operations and expanding BE's vaccine presence. The company has also focused on partnerships with global healthcare agencies and expanding their vaccine pipeline, including generic vaccines and novel vaccines. BE has a strong focus on quality, accessibility and innovation in healthcare.

Philanthropy

Specific philanthropy amounts for Mahima Datla were not found in the search results.